Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling

Human Pathology
Rajal B ShahAngelo M DeMarzo

Abstract

ERG and PTEN biomarkers are increasingly being analyzed on prostate core biopsies (NBXs); ERG as a marker of clonality and number of separately arising tumor foci and PTEN for prognostic information. Yet, in patients with multiple biopsy cores positive for cancer (PCa), there is no standardized approach for interrogation of these biomarkers in terms of the number of positive cores to evaluate. A total of 194 NBX cases containing more than one positive core with cancer were evaluated for ERG overexpression and PTEN loss by immunostaining (immunohistochemistry) of all positive cores. ERG overexpression or PTEN loss in at least one cancer core was present in 111 (57%) and 69 (36%) cases respectively. ERG overexpression was significantly associated with PTEN loss (P < .0001), and PTEN loss was associated with a high Gleason score (P < .0001). Inter- and intra-tumor core staining heterogeneity for ERG overexpression occurred in 42% and 5% cases and for PTEN loss both intra- and inter-tumor core heterogeneity was 68%. PTEN staining was highly discordant between PCa sites regardless of laterality. When the Gleason score was non-uniform across PCa sites, the combination of cores showing the highest Gleason score and largest tumor volum...Continue Reading

References

Jul 12, 2002·The Urologic Clinics of North America·Hartwig HulandHans Lilja
Aug 13, 2005·The American Journal of Surgical Pathology·Jonathan I EpsteinUNKNOWN ISUP Grading Committee
Oct 29, 2005·Science·Scott A TomlinsArul M Chinnaiyan
Feb 24, 2006·The Prostate·Jerod BertramChristopher J Ong
Mar 6, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Rohit MehraRajal B Shah
May 29, 2007·The American Journal of Surgical Pathology·Sven PernerMark A Rubin
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Juan-Miguel MosqueraMark A Rubin
May 2, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Bo HanRajal B Shah
Jul 9, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Juan-Miguel MosqueraMartin G Sanda
Jul 24, 2010·Neoplasia : an International Journal for Oncology Research·Kyung ParkMark A Rubin
Apr 19, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Geert J L H van LeendersJan Trapman
Jun 17, 2011·The American Journal of Surgical Pathology·Alcides ChauxGeorge J Netto
Sep 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tamara L LotanAngelo M De Marzo
Feb 15, 2012·Nature Reviews. Urology·Philip RosenAlbert Dobi
Jun 12, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Alcides ChauxGeorge J Netto
Jun 28, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Andreas PetterssonLorelei A Mucci
Sep 29, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Maisa YoshimotoAndrew J Evans
Apr 26, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Antje KrohnSarah Minner
May 21, 2014·Nature Reviews. Clinical Oncology·Linda M JohnsonPeter L Choyke
Jul 6, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Tamara L LotanDavid M Berman
Aug 8, 2014·International Journal of Urology : Official Journal of the Japanese Urological Association·Prabhakar MithalStephen J Freedland

❮ Previous
Next ❯

Citations

Nov 28, 2015·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Stephen J MurphyJohn C Cheville
Mar 19, 2016·Pathology International·Rajal B Shah, Ming Zhou
Aug 27, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Kanerva LahdensuoTuomas Mirtti
Oct 19, 2016·The Journal of Pathology·Daniel Nava RodriguesJohann de Bono
Dec 13, 2016·Advances in Anatomic Pathology·Giovanna A GiannicoOmar Hameed
Jun 18, 2017·Targeted Oncology·Daniel P Petrylak, E David Crawford
Feb 21, 2018·Nature Reviews. Urology·Tamara JamaspishviliTamara L Lotan
Nov 17, 2015·Cancer Informatics·Nabila Bennani-Baiti, Idriss M Bennani-Baiti
Feb 27, 2016·The International Journal of Biological Markers·Malik W AhmedIshrat Mahjabeen
Jan 7, 2017·Clinical Science·Helen M WiseNicholas R Leslie
Dec 10, 2016·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·Dorthe SkovgaardAndreas Kjaer
Dec 12, 2019·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C E MoraisF Tavora
Aug 4, 2020·Asian Journal of Urology·Ieva EringyteClaire E Fletcher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.